Nock, B.A.; Kaloudi, A.; Kanellopoulos, P.; Janota, B.; Bromińska, B.; Iżycki, D.; Mikołajczak, R.; Czepczynski, R.; Maina, T.
[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. Cancers 2021, 13, 5093.
https://doi.org/10.3390/cancers13205093
AMA Style
Nock BA, Kaloudi A, Kanellopoulos P, Janota B, Bromińska B, Iżycki D, Mikołajczak R, Czepczynski R, Maina T.
[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. Cancers. 2021; 13(20):5093.
https://doi.org/10.3390/cancers13205093
Chicago/Turabian Style
Nock, Berthold A., Aikaterini Kaloudi, Panagiotis Kanellopoulos, Barbara Janota, Barbara Bromińska, Dariusz Iżycki, Renata Mikołajczak, Rafał Czepczynski, and Theodosia Maina.
2021. "[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes" Cancers 13, no. 20: 5093.
https://doi.org/10.3390/cancers13205093
APA Style
Nock, B. A., Kaloudi, A., Kanellopoulos, P., Janota, B., Bromińska, B., Iżycki, D., Mikołajczak, R., Czepczynski, R., & Maina, T.
(2021). [99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. Cancers, 13(20), 5093.
https://doi.org/10.3390/cancers13205093